The Seattle Cancer Care Alliance (SCCA), located in Seattle, Washington, is part of a dynamic collaboration among three organizations known nationally and internationally for their patient care and research: Fred Hutchinson Cancer Research Center, University of Washington, and Seattle Children's. Over the past 25 years, these institutions have worked together to support their mission of adult and pediatric oncology patient care services, research and education.
The Cellular Therapy Lab (CTL) at the Seattle Cancer Care Alliance (SCCA) is on the cutting edge of new technologies for cancer therapy, including cell-based immunotherapy. We are committed to advancing treatment options for our patients through the translation of innovative research into clinical practice. We collaborate with our Alliance members (University of Washington, Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital) as well as corporate entities.
CTL is responsible for all minimally manipulated therapeutic cell processing occurring at the SCCA. Procedures range from cryopreservation to flow cytometric enumeration of cell proportions to more complex procedures such as cell selection, enrichment, and depletion. The laboratory is regulated by the FDA cGTP/cGMP standards, maintains CAP certification, and is accredited by the Joint Commission and FACT.
We currently have an opening for a Cellular Therapy Technologist I. This a full-time position (40 hours per week). This position requires a flexible schedule that can include on-call, evenings, weekends, and holidays.
